Tech Company M&A Transactions
Agensys Acquisition
Agensys, based in Santa Monica, was acquired by Astellas Pharma. The transaction price was $387 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/27/2007
Transaction Type
M&A
Amount
$387,000,000
M&A Terms
All cash transaction of $387 million up front plus the addition of a maximum of $150 million in performance and milestone earnout.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1545 17th St.
Santa Monica, CA 90404
USA
Santa Monica, CA 90404
USA
Phone
Website
Email Address
Overview
Agensys, Inc. is developing a pipeline of therapeutic fully human monoclonal antibodies (MAbs) to treat solid tumor cancers based on its own proprietary targets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Donald Rice
Chief Financial Officer
Paul Kanan
Chief Scientific Officer
Aya Jakobovits
VP - Bus. Development
Christopher Morl
Browse more venture capital transactions:
Prev: 11/27/2007: Platform Solutions venture capital transaction
Next: 11/27/2007: Qwaq venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site come from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs